# EDGAR Filing Document

**Accession Number:** 0000088000
**File Stem:** 0001193125-26-164084
**Filing Date:** 2026-4
**Character Count:** 105252
**Document Hash:** 6210f56fa0b950eda2baa2695c83e2c6
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-26-164084.hdr.sgml**: 20260420

**ACCESSION NUMBER**: 0001193125-26-164084

**CONFORMED SUBMISSION TYPE**: DEF 14A

**PUBLIC DOCUMENT COUNT**: 16

**CONFORMED PERIOD OF REPORT**: 20260609

**FILED AS OF DATE**: 20260420

**DATE AS OF CHANGE**: 20260420

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Horizon Kinetics Holding Corp
- **CENTRAL INDEX KEY:** 0000088000
- **STANDARD INDUSTRIAL CLASSIFICATION:** INVESTMENT ADVICE [6282]
- **ORGANIZATION NAME:** 02 Finance
- **EIN:** 840920811
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** DEF 14A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-13458
- **FILM NUMBER:** 26875402

**BUSINESS ADDRESS:**
- **STREET 1:** 470 PARK AVE S.
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10016
- **BUSINESS PHONE:** 6462912300

**MAIL ADDRESS:**
- **STREET 1:** 470 PARK AVE S.
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10016

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Scott's Liquid Gold - Inc.
- **DATE OF NAME CHANGE:** 20180828

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** SCOTTS LIQUID GOLD INC
- **DATE OF NAME CHANGE:** 19920703

?xml version='1.0' encoding='ASCII'? DEF 14A

**UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549SCHEDULE** 14A **Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934** 

**(Amendment No.)**

Filed by the Registrant 

Filed by a Party other than the Registrant 

Check the appropriate box:

 Preliminary Proxy Statement

 Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

 Definitive Proxy Statement

 Definitive Additional Materials

 Soliciting Material under Rule 14a-12

Horizon Kinetics Holding Corporation

**(Name of Registrant as Specified In Its Charter)**![img223293286_0.jpg](img223293286_0.jpg)**(Name of Person(s) Filing Proxy Statement, if other than the Registrant)**

Payment of Filing Fee (Check the appropriate box):

 No fee required.

 Fee paid previously with preliminary materials.

 Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

------

![img223293286_1.jpg](img223293286_1.jpg)

April 20, 2026

Dear Stockholder:

Earlier this month, we suffered a great loss with the unexpected passing of our visionary co-founder, Mr. Murray Stahl. Mr. Stahl co-founded Horizon Kinetics in 1994 and was instrumental in transforming it into the publicly traded company it is today. Murray's dedication, wisdom, and leadership will be felt for generations to come.

The Company will continue to honor Murray's legacy and build upon the success of the company he founded. It is our honor to lead the company in the fulfillment of those objectives. On behalf of the Board and the management of Horizon Kinetics, we thank you for your support.

\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*

You are cordially invited to attend the 2026 Annual Meeting of Stockholders of Horizon Kinetics Holding Corporation, which will be held both virtually via the Internet at www.virtualshareholdermeeting.com/HKHC2026 and in person at the offices of Horizon Kinetics Holding Corporation, 470 Park Avenue South, 3rd Floor, New York, New York 10016, on Tuesday, June 9, 2026, at 2:00 p.m., Eastern Time. The official Notice of Annual Meeting together with a proxy statement and proxy card are enclosed. Please give this information your careful attention.

We invite all stockholders to attend the meeting. Whether or not you expect to attend the Annual Meeting, we urge you to complete, sign, date and promptly return the accompanying proxy card in the enclosed postage-paid envelope or vote by Internet by following the instructions in the Notice of Annual Meeting to ensure your representation at the meeting. You can revoke your proxy at any time before it is voted by delivering written notice to our General Counsel and Secretary at our principal executive office, by signing and mailing to us a proxy card bearing a later date, by changing your vote by Internet (if you voted by Internet), or by attending the meeting and voting then.

Sincerely,

/s/Steven Bregman

/s/Peter Doyle

Steven Bregman and Peter Doyle

Co-Chief Executive Officers

HORIZON KINETICS HOLDING CORPORATION

470 PARK AVENUE S. • NEW YORK, NEW YORK 10016 • T. (646) 291-2300 • https://hkholdingco.com/

------

**TABLE OF CONTENTS** 

---

| | |
|:---|:---|
|  | **<u>Page</u>** |
| [<u>Notice of Annual Meeting</u>](#notice_of_annual_meeting) | ii |
| [<u>General Questions and Answers for the Annual Meeting</u>](#general_qs_and_a_for_the_annual_meeting) | 1 |
| [<u>General Questions and Answers on the Procedures for Voting</u>](#questions_answers_procedures_for_voting) | 3 |
| [<u>General Question and Answers – Other Information</u>](#other_information) | 4 |
| [<u>Proposal 1 – Election of Directors</u>](#proposal_1) | 5 |
| [<u>Corporate Governance Information</u>](#corporate_governance_information) | 7 |
| [<u>Board Leadership Structure</u>](#board_leadership_structure) | 9 |
| [<u>Management Succession Planning and Development</u>](#management_succession_planning) | 10 |
| [<u>Board's Role in Risk Oversight</u>](#board_role_oversight) | 10 |
| [<u>Risks Related to Compensation Policies and Practice</u>](#compensation_policies) | 10 |
| [<u>Stockholder Recommendations for Director Candidates</u>](#stockholder_recommendations) | 10 |
| [<u>Communications with the Board</u>](#communications_with_board) | 11 |
| [<u>Director Compensation</u>](#director_compensation) | 11 |
| [<u>Executive Officer Biographies</u>](#executive_bios) | 12 |
| [<u>Executive Compensation</u>](#exec_compensation) | 13 |
| [<u>Insider Trading Policy</u>](#insider_trading_policy) | 16 |
| [<u>Pay-Versus-Performance Disclosure</u>](#pay_versus_performance) | 16 |
| [<u>Proposal 2 – Ratification of Appointment of Registered Public Accounting Firm</u>](#proposal_2) | 17 |
| [<u>Proposal 3 – Approval, on a Non-Binding, Advisory Basis, of the Compensation of HKHC's Named Executive Officers</u>](#proposal_3) | 19 |
| [<u>Certain Relationships and Related Transactions</u>](#certain_relationships) | 20 |
| [<u>Security Ownership of Certain Beneficial Owners and Management</u>](#security_ownership) | 21 |
| [<u>Report of the Audit Committee</u>](#ac_report) | 23 |
| [<u>Section 16(A) Beneficial Owner Reporting Compliance</u>](#beneficial_owner_compliance) | 24 |
| [<u>Stockholder Proposals and Director Nominations</u>](#stockholder_proposals) | 24 |
| [<u>Annual Report</u>](#annual_report) | 24 |
| [<u>Householding of Proxy Materials</u>](#householding_proxy_materials) | 24 |
| [<u>Other Matters</u>](#other_matters) | 25 |

---

i

------

**Horizon Kinetics Holding Corporation**

**NOTICE OF ANNUAL MEETING OF STOCKHOLDERS**

**TO BE HELD ON JUNE 9, 2026**

To the Stockholders of Horizon Kinetics Holding Corporation:

NOTICE IS HEREBY GIVEN that the annual meeting of stockholders of Horizon Kinetics Holding Corporation ("HKHC," the "Company," "we," "us" or "our") will be held both virtually via the Internet at www.virtualshareholdermeeting.com/HKHC2026 and in person at the offices of Horizon Kinetics Holding Corporation, located at 470 Park Avenue South, 3<sup>rd</sup>Floor, New York, New York 10016, on Tuesday, June 9, 2026, at 2:00 p.m., Eastern Time, to consider and vote on the following proposals:

---

| | | |
|:---|:---|:---|
|  | &nbsp;&nbsp;**Proposal** | &nbsp;&nbsp;**Board Recommendation** |
| &nbsp;&nbsp;Proposal 1. | &nbsp;&nbsp;The election of the directors to hold office until the next annual meeting of HKHC's stockholders and until their successors have been duly elected and qualified or until their earlier death, resignation or removal; | &nbsp;&nbsp;FOR ALL NOMINEES |
| &nbsp;&nbsp;Proposal 2. | &nbsp;&nbsp;The ratification of the appointment of CBIZ CPAs P.C. as HKHC's independent registered public accounting firm for the year ending December 31, 2026; and | &nbsp;&nbsp;FOR |
| &nbsp;&nbsp;Proposal 3. | &nbsp;&nbsp;To approve, on a non-binding, advisory basis, the compensation of HKHC's named executive officers. | &nbsp;&nbsp;FOR |

---

In addition, we will consider the transaction of such other business as may properly come before the meeting or at any adjournments or postponements.

The foregoing items of business are more fully described in the attached proxy statement.

Only stockholders of record at the close of business on April 24, 2026, are entitled to notice of, and to vote at, the annual meeting and any adjournments or postponements thereof. A holder of shares of our common stock as of the record date is entitled to one vote at the meeting or by proxy for each share of common stock owned by such holder on all matters properly brought before the annual meeting or at any adjournments or postponements.

All of our stockholders are invited to attend the annual meeting. Whether or not you expect to attend the annual meeting, we urge you to complete, sign, date and promptly return the accompanying proxy card in the enclosed postage-paid envelope to assure your representation at the meeting. You may also vote by Internet at www.virtualshareholdermeeting.com/HKHC2026 using the control number shown on your proxy card or voting instruction card. You can revoke your proxy at any time before it is voted by delivering written notice to our General Counsel and Secretary at our principal executive office located at 470 Park Ave S., New York, New York 10016, by signing and mailing to us a proxy bearing a later date, by changing your vote by Internet (if you voted by Internet), or by attending the annual meeting and voting then.

If you are the beneficial owner of shares of our common stock held in street name, you will receive voting instructions from your broker, bank or other nominee (who must be the stockholder of record). The voting instructions will provide details regarding how to vote these shares. Additionally, you may vote these shares at the annual meeting if you have requested and received a legal proxy from your broker, bank, or other nominee giving you the right to vote the shares at the annual meeting and you complete the legal proxy and present it to us electronically at the annual meeting. If you hold your shares in street name, nominees will not have discretion to vote these shares on the election of directors, or the approval, on a non-binding, advisory basis, of the compensation of our named executive officers. Accordingly, if your shares are held in street name and you do not submit voting instructions to your broker, bank, or other nominee, these shares will not be counted in determining the outcome on Proposals 1 and 3 set forth in this proxy statement at the annual meeting. If you hold your shares in street name, we encourage you to provide voting instructions to your broker, bank, or other nominee so that your voice is heard on these proposals.

ii

------

We expect to mail this proxy statement and the accompanying proxy card to our stockholders on or about April 30, 2026.

iii

------

**NOTICE OF INTERNET AVAILABILITY OF PROXY MATERIALS**

**Important Notice Regarding Internet Availability of Proxy Materials for the Stockholder Meeting to be Held on June 9, 2026**

The proxy materials for the Company's Annual Meeting of Stockholders, including the 2025 Annual Report to Stockholders, the Proxy Statement and any other additional soliciting materials, are available over the Internet by accessing our website at www.hkholdingco.com. Other information on our website does not constitute part of the Company's proxy materials.

By Order of the Board of Directors

Horizon Kinetics Holding Corporation

/s/Steven Bregman

/s/Peter Doyle

Steven Bregman and Peter Doyle

Co-Chief Executive Officers

iv

------

**HORIZON KINETICS HOLDING CORPORATION PROXY STATEMENT FOR 2026 ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON JUNE 9, 2026**

**GENERAL QUESTIONS AND ANSWERS**

The following questions and answers are intended to provide brief answers to frequently asked questions concerning the proposals described in this proxy statement and the proxy solicitation process. These questions and answers do not, and are not intended to, address all the questions that may be important to you. You should carefully read the remainder of this proxy statement. We expect to mail this proxy statement and the accompanying proxy card to the stockholders of Horizon Kinetics Holding Corporation ("HKHC," the "Company," "we," "us" or "our") on or about April 30, 2026.

**The Annual Meeting**

**Q: When and where is the annual meeting?**

A: The annual meeting will be held both virtually via the Internet at http://www.virtualshareholdermeeting.com/HKHC2026 and in person at the offices of Horizon Kinetics Holding Corporation, located at 470 Park Avenue South, 3<sup>rd</sup> Floor, New York, New York 10016, on Tuesday, June 9, 2026, at 2:00 p.m., Eastern Time.

**Q: What am I being asked to vote on?**

A: Our stockholders are being asked to vote on the following proposals at the annual meeting:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Proposal 1 - The election of the directors to hold office until the next annual meeting of HKHC's stockholders and until their successors have been duly elected and qualified or until their earlier death, resignation or removal;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Proposal 2 - The ratification of the appointment of CBIZ CPAs P.C. as HKHC's independent registered public accounting firm for the year ending December 31, 2026; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Proposal 3 - To approve, on a non-binding, advisory basis, the compensation of HKHC's named executive officers.

**Q: How does the Board of Directors recommend that I vote?**

A: The Board of Directors recommends that you vote your shares (i) "FOR" each of the director nominees for election to the Board of Directors, (ii) "FOR" the ratification of the appointment of CBIZ CPAs P.C. as HKHC's independent registered public accounting firm for the year ending December 31, 2026, and (iii) "FOR" the approval, on a non-binding, advisory basis, of the compensation of HKHC's named executive officers.

If you submit your properly executed proxy without voting instructions, your shares represented by that proxy will be voted as recommended by the Board of Directors.

**Q: Who is entitled to vote at the annual meeting?**

A: Stockholders of record at the close of business on April 24, 2026 (the "record date") are entitled to notice of, and to vote at, the annual meeting and any adjournments or postponements thereof. A holder of shares of our common stock as of the record date is entitled to one vote at the meeting or by proxy for each share of common stock owned by such holder on all matters properly brought before the annual meeting or at any adjournments or postponements thereof. As of April 24, 2026, there were 18,635,321 shares of common stock outstanding and entitled to vote on each of the proposals.

------

**Q: What constitutes a quorum?**

A: We must have a quorum in order to carry out the business of the annual meeting. This means at least a majority of the shares of common stock issued and outstanding as of the record date must be represented at the annual meeting, either by proxy or in person. Abstentions and broker non-votes, which are described in more detail below, are counted as shares present at the annual meeting for purposes of determining whether a quorum exists.

**Q: What is the difference between holding shares as a "stockholder of record" and as a "beneficial owner"?**

A: Stockholder of Record: A stockholder of record holds shares registered directly in the stockholder's name with our transfer agent. As a stockholder of record, you have the right to grant your voting proxy directly to us in accordance with the procedures described below or to vote at the annual meeting.

Beneficial Owner: If your shares are held through a bank, broker, or other nominee, you are the "beneficial owner" of shares held in "street name," and these proxy materials are being forwarded to you by your bank, broker or other nominee, which is considered, with respect to those shares, the stockholder of record. As the beneficial owner, you have the right to direct your bank, broker or other nominee on how to vote your shares by completing the instructions provided to you by your bank, broker, or other nominee. However, since you are not a stockholder of record, you may not vote these shares at the annual meeting unless you obtain a valid proxy from your bank, broker, or other nominee (who must be the stockholder of record).

**Q: What is a broker non-vote?**

A: Generally, a broker non-vote occurs when a bank, broker, or other nominee that holds shares in "street name" for customers is precluded from exercising voting discretion on a particular proposal because (i) the beneficial owner has not instructed the bank, broker, or other nominee how to vote, and (ii) the bank, broker, or other nominee lacks discretionary voting power to vote such shares. A bank, broker, or other nominee does not have discretionary voting power with respect to the approval of "non-routine" matters, absent specific voting instructions from the beneficial owners of such shares.

Proposals 1 and 3 are considered "non-routine" matters, on which banks, brokers, and other nominees are not allowed to vote unless they have received voting instructions from the beneficial owners of such shares. The proposal to ratify the appointment of CBIZ CPAs P.C. as HKHC's independent registered public accounting firm for the year ending December 31, 2026 (Proposal 2), is considered a routine matter on which banks, brokers, and other nominees may vote in their discretion on behalf of beneficial owners who have not provided voting instructions. If you are a beneficial owner, your bank, broker or other nominee will send you instructions on how you can instruct them to vote on Proposal 2. If you are a beneficial owner and you do not provide voting instructions, your bank, broker, or other nominee will have discretionary authority to vote your shares with respect to Proposal 2.

**Q: What vote is required to approve each proposal?**

A: Proposal 1: Directors must be elected by a plurality of the voting power of the shares present in person or represented by proxy at the annual meeting and entitled to vote on the election of directors. Plurality voting simply means that the number of candidates getting the highest number of votes cast "FOR" their election at the annual meeting will be elected. With respect to the election of directors, you may vote "FOR" or "WITHHOLD" authority to vote for each of the nominees for election to the Board of Directors. If you "WITHHOLD" authority to vote with respect to one or more director nominees, your vote will have no effect on the election of such nominees. Broker non-votes will have no effect on the election of the nominees.

Proposal 2: The ratification of the appointment of CBIZ CPAs P.C. as HKHC's independent registered public accounting firm for the year ending December 31, 2026 requires the affirmative "FOR" vote of a majority of the shares present in person or represented by proxy at the annual meeting (meaning that of the shares represented at the annual meeting and entitled to vote, a majority of them must be voted "FOR" the proposal for it to be approved). You may vote "FOR," "AGAINST," or "ABSTAIN" with respect to this proposal. This proposal is considered a "routine" matter for which banks, brokers, and other nominees may vote in their discretion on behalf

------

of beneficial owners who have not provided voting instructions. Abstentions will have the same effect as a vote "AGAINST" this proposal.

Proposal 3: The proposal to approve, on a non-binding, advisory basis, the compensation of HKHC's named executive officers requires the affirmative "FOR" vote of a majority of the shares present in person or represented by proxy at the annual meeting. You may vote "FOR," "AGAINST," or "ABSTAIN" with respect to this proposal. Abstentions will have the same effect as a vote "AGAINST" this proposal, and broker non-votes will have no effect on the vote for this proposal.

**Procedures for Voting**

**Q: Who is entitled to vote?**

A: Only stockholders of record as of the close of business on April 24, 2026, the record date, will be entitled to vote on the proposals at the annual meeting. Each share of common stock is entitled to one vote.

**Q: How do I vote?**

A: If you are the record holder of your shares, you can vote by attending the annual meeting, or by completing, signing and returning your proxy card in the enclosed postage-paid envelope. You can also vote by Internet at <u>www.virtualshareholdermeeting.com/HKHC2026</u> using the control number shown on your proxy card or voting instruction card.

If your shares are held by your broker as your nominee (in "street name"), you will need to obtain a proxy form from the institution that holds your shares and follow the instructions included on that form regarding how to instruct your broker to vote your shares. If your shares are held in street name, your voting instruction card may contain instructions from your broker that allow you to vote your shares using the Internet or telephone. Please consult with your broker if you have any questions regarding the electronic voting of your shares held in street name.

**Q: Is my proxy revocable, and can I change my vote?**

A: If you are a stockholder of record you may revoke your proxy at any time before it is officially voted by doing one of the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Sending a written notice revoking your proxy to our General Counsel and Secretary at Horizon Kinetics Holding Corporation, 470 Park Ave S., New York, New York 10016;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Signing and mailing to us a proxy bearing a later date;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Changing your vote by Internet (if you voted by Internet); or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Attending our annual meeting and voting then.

If you are not a stockholder of record, but instead hold your shares in "street name" through a bank, broker, or other nominee, the above-described options for revoking your proxy do not apply. Instead, you will need to follow the instructions provided to you by your bank, broker, or other nominee in order to revoke your proxy and submit new voting instructions.

**Q: Is my vote confidential?**

A: Yes. Only the inspector of votes and certain of our employees will have access to your proxy card.

------

**Other Information**

**Q: Who is soliciting my proxy and who will pay the solicitation expenses?**

A: The Company is soliciting your proxy by and on behalf of our Board of Directors, and we will pay the cost of preparing and distributing this proxy statement and the cost of soliciting votes. We will reimburse stockbrokers and other custodians, nominees, and fiduciaries for forwarding proxy and solicitation material to the owners of our common stock.

**Q: Who can help answer my additional questions?**

A: Stockholders who would like additional copies, without charge, of this proxy statement or have additional questions about this proxy statement, including the procedures for voting their shares, should contact:

Jay Kesslen, General Counsel and Secretary

Horizon Kinetics Holding Corporation

470 Park Ave S.

New York, New York 10016

Telephone: (646) 291-2300

This question and answer section is qualified in its entirety by the more detailed information contained in this proxy statement.

**This proxy statement contains important information that should be read before you vote on the proposals herein. You are strongly urged to read this proxy statement in its entirety. You are also strongly urged to read our Annual Report on Form 10-K for the year ended December 31, 2025, filed with the Securities and Exchange Commission ("SEC") on March 12, 2026 (the "2025 Form 10-K"), which is being sent to you with this proxy statement.**

------

**PROPOSAL 1: ELECTION OF DIRECTORS**

Our Bylaws provide that the Board of Directors of the Company (the "Board" or the "Board of Directors") will consist of one or more members, each of whom must be a natural person. Our Bylaws further provide that the number of directors shall be as determined from time to time by resolution of the Board. In accordance with our Bylaws, the Board had determined the number of directors to be seven. Due to the untimely passing of Mr. Stahl, there are six directors presented herein while the Board considers additional nominees, if any. Mr. Stahl served as Chairman of the Board and a director during the full fiscal year 2025 until his passing on April 7, 2026.

Each director elected at the 2026 Annual Meeting will serve until the 2027 Annual Meeting and until his or her successor has been duly elected and qualified or until his or her earlier death, resignation or removal. The Board of Directors has nominated the nominees listed below. Each nominee has consented to being named in this proxy statement and to serve if elected.

We have no reason to believe that any of the nominees will not serve if elected. If any of them should become unavailable to serve as a director, and if the Board of Directors designates a substitute nominee, the persons named in the accompanying proxy will vote for the substitute nominee designated by the Board of Directors, unless a contrary instruction is given in the proxy.

Each stockholder is entitled to cast one vote for each director nominee per share of common stock held by them at the close of business on April 24, 2026. Directors must be elected by a plurality of the voting power of the shares present in person or represented by proxy at the annual meeting and entitled to vote on the election of directors. Plurality voting simply means that the number of candidates getting the highest number of votes cast "FOR" their election at the annual meeting will be elected. With respect to the election of directors, you may vote "FOR" or "WITHHOLD" authority to vote for each of the nominees for election to the Board of Directors. If you "WITHHOLD" authority to vote with respect to one or more director nominees, your vote will have no effect on the election of such nominees. Broker non-votes will have no effect on the election of the nominees.

**Nominees**

The persons nominated to be directors are listed below. The following information is submitted concerning the nominees for election as directors:

---

| | | |
|:---|:---|:---|
| **Name** | **Age** | **Position(s) With HKHC** |
| Steven Bregman | 67 | Co-Chief Executive Officer (appointed April 2026) and Director |
| Peter Doyle | 63 | Co-Chief Executive Officer (appointed April 2026) and Director |
| Daniel J. Roller | 45 | Director |
| Alice C. Brennan | 73 | Director |
| Allison Nagelberg | 61 | Director |
| Brent D. Rosenthal | 54 | Director |

---

**THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS A VOTE FOR THE APPROVAL OF EACH OF THE DIRECTOR NOMINEES.**

The biographical information for each director nominee is set forth below.

*Steven Bregman* is the Co-Chief Executive Officer of HKHC and a member of the Board. He serves in such roles for Horizon Kinetics and is one of its co-founders. He is a senior member of Horizon Kinetics' research team and a member of the Investment Committee and supervises all research reports produced by Horizon Kinetics. Mr. Bregman serves as the Co-Portfolio Manager for RENN Fund, Inc. (NYSE: RCG), several of the Kinetics Mutual Funds, Inc., the President and CFO of FRMO Corp. (OTCID: FRMO), and is a member of the Board of Directors of Winland Electronics, Inc (OTCID: WELX). He received a BA from Hunter College, and his CFA® Charter in 1989.

*Peter Doyle* is the Co-Chief Executive Officer and a member of the Board. He previously served as Managing Director and member of the Board of Horizon Kinetics and is one of its co-founders. He is a senior member of the

------

research team, and a member of the Investment Committee. He is also president of Kinetics Mutual Funds, Inc. Mr. Doyle also serves as a Co-Portfolio Manager for RENN Fund, Inc. (NYSE: RCG), and for several registered investment companies, private funds, and institutional separate accounts. He is also responsible for oversight of Horizon Kinetics' marketing and sales activities Additionally, Mr. Doyle is the Chairman and Vice President of FRMO Corp. (OTCID: FRMO). Previously, Mr. Doyle was with Bankers Trust Company (1985-1994) as a Senior Investment Officer, where he also served on the Finance, Utility and REIT Research sub-group teams. Mr. Doyle received a BS from St. John's University and an MBA from Fordham University.

*Daniel J. Roller* is a member of the Board. He previously served as the Chairman of the Board of Scott's Liquid Gold-Inc., a Colorado corporation ("Scott's"). He is the founder, President, and Chief Investment Officer of Maran Capital Management, LLC, a Denver-based investment firm he founded in 2015. Maran Capital is focused on making concentrated, fundamentally driven, long-term oriented investments in publicly-traded small capitalization companies. In 2026, he was appointed to the board for Pure Cycle Corporation (NASDAQ: PCYO). Mr. Roller has over 20 years of investment research and management experience and has advised numerous public and private companies on topics such as M&A, capital allocation, corporate governance, and strategy. Mr. Roller holds a B.S.E. in Electrical Engineering and Computer Science from Duke University.

*Alice C. Brennan* is a member of the Board. She serves as a director of RENN Fund, Inc. (NYSE: RCG) and FRMO Corp. (OTCID: FRMO), including as a member of their audit committees and nominating and governance committees. She is also a director of independent power producer and climate-focused investment manager Greenbacker Renewable Energy Company II, serving on the audit committee and chairing the nominating and governance committee. Previously, she served as chief compliance officer at Verizon Wireless (2000-2014) and Bristol-Myers Squibb Company (1994-1999), where she led risk management, M&A, governance, and corporate and intellectual property law initiatives. Ms. Brennan holds a BA in Chemistry and Biology from Skidmore College, an MA in Microbiology and Immunology from Columbia University and a JD from Hofstra University.

*Allison Nagelberg* is a member of the Board. From 2000 until 2019, Ms. Nagelberg was the General Counsel of Monmouth Real Estate Investment Corporation (NYSE: MNR), a public REIT investing in net-leased industrial properties, where she was responsible for legal oversight of financial, capital markets and property transactions, ESG, SEC and NYSE compliance, legislative and regulatory policy analysis, human resources, investor relations and risk management. She also served as General Counsel of UMH Properties, Inc. (NYSE: UMH), an affiliated public REIT investing in residential real estate, from 2000 until 2013, and as General Counsel of Monmouth Capital Corporation (NASDAQ: MONM), an affiliated public REIT investing in net-leased industrial properties, from 2000 until 2007. She serves as an independent director of GoodHaven Funds Trust. Ms. Nagelberg holds a BA in Economics and Philosophy from Tufts University, an MBA in Finance from Rutgers University and a JD from New York University.

*Brent D. Rosenthal* is a member of the Board. Mr. Rosenthal is the founder of Mountain Hawk Capital Partners, LLC, an investment fund focused on small and microcap equities. Currently, Mr. Rosenthal serves on the boards of directors of Pitney Bowes (NYSE: PBI), where he is the non-executive Chairman, and Syntec Optics Holdings, Inc. (NASDAQ: OPTX). Previously he has served as a director of Comscore, Inc. (NASDAQ: SCOR), Rentrak Corporation (NASDAQ: RENT), FLYHT Aerospace Solutions Ltd (OTCQX: FLYLF), RiceBran Technologies (OTCPK: RIBT), and SITO Mobile (NASDAQ: SITO), as well as Advisor to the board of Park City Group, Inc. (NASDAQ: PCYG), the parent company of ReposiTrak Inc. Earlier in his career, Mr. Rosenthal was a Partner in affiliates of W.R. Huff Asset Management, an employee-owned investment manager, where he worked from 2002 to 2016, during which time he was an Advisor to the boards of directors of Virgin Media (NASDAQ: VMED) and Time Warner Cable (NYSE:TWC). Earlier in his career, Mr. Rosenthal was director of mergers and acquisitions for RSL Communications Ltd. and served emerging media companies for Deloitte & Touche LLP. Mr. Rosenthal is an inactive Certified Public Accountant. Mr. Rosenthal earned his B.S. from Lehigh University and M.B.A. from the S.C. Johnson Graduate School of Management at Cornell University.

------

**Corporate Governance Information**

The Board of Directors held 5 meetings during 2025. All director nominees who served in the capacity of director during the 2025 year attended all the meetings that were held. The standing committees of the Board of Directors currently consist of the Audit Committee, the Compensation Committee, and the Nominating & Corporate Governance Committee. The membership and duties of these committees are described below.

---

| |
|:---|
| **Non-Management Directors(1) (2)** |
| Daniel J. Roller<br> M |
| Alice C. Brennan<br> M<br> C |
| Allison Nagelberg<br> M<br> C |
| Brent D. Rosenthal<br> C<br> M |
| M Committee member |
| C Committee chair |
| (1) The Board of Directors has determined that all members of the Audit, Compensation, and Nominating & Corporate Governance Committees are "independent directors" under applicable independence standards. |
| (2) The Board of Directors has determined that Brent Rosenthal, Allison Nagelberg, Alice Brennan and Daniel Roller are qualified as Audit Committee financial experts within the meaning of the regulations of the Securities and Exchange Commission ("SEC"). |

---

*<u>Board Committees</u>*

*Audit Committee*. The Audit Committee operates pursuant to a charter approved by our Board of Directors, which the Audit Committee reviews periodically to determine if revisions are necessary or appropriate. A copy of the charter is posted on our website at *https://hkholdingco.com/corporate-documents/*. In addition, a copy of the charter is available upon written request to our General Counsel and Secretary at our principal executive office (470 Park Ave S., New York, New York 10016). The Audit Committee monitors (1) the integrity of our financial statements, (2) the qualifications and independence of our independent registered public accounting firm, (3) the performance of our independent registered public accounting firm, and (4) our compliance with legal and regulatory requirements. The Audit Committee has the sole authority to appoint or replace our independent registered public accounting firm, and pre-approves all audit engagement fees and terms and all non-audit services. The Audit Committee, to the extent it deems necessary or appropriate, shall:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Review and discuss with our management and independent registered public accounting firm our annual audited financial statements, including disclosures made in management's discussion and analysis, and recommend to the Board whether the audited financial statements should be included in our Form 10-K;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Review and discuss with our management and independent registered public accounting firm our quarterly financial statements, including disclosures made in management's discussion and analysis for inclusion in our Form 10-Q documents;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Discuss with our management and independent registered public accounting firm significant financial reporting issues and judgments made in connection with the preparation of our financial statements;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Discuss with our management and independent registered public accounting firm any earnings press releases;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Discuss with our management and independent registered public accounting firm the effect of regulatory and accounting initiatives as well as any off-balance sheet structures on our financial statements;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Discuss with our management our major financial risk exposures, if any, and the steps our management has taken to monitor and control such exposures;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Review the experience and qualifications of the senior members of our independent registered public accounting firm's team;

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Obtain and review a report from our independent registered public accounting firm at least annually regarding (a) the firm's internal quality-control procedures, (b) any material issues raised by the most recent quality-control review of the firm, or by any inquiry or investigation by governmental or professional authorities within the preceding five years respecting one or more independent audits carried out by the firm, (c) any steps taken to deal with any such issues, and (d) all relationships between the firm and the Company;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Review reports and disclosures of insider and affiliated party transactions;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Advise the Board with respect to the Company's policies and procedures regarding compliance with applicable laws and regulations and with any code of business conduct;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Discuss with our management and independent registered public accounting firm any correspondence with regulators or governmental agencies and any employee complaints or published reports which raise material issues regarding our financial statements or accounting policies;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Discuss with our counsel legal matters that may have a material impact on the financial statements or our compliance policies;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Approve or reject all related party transactions; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Establish and oversee any anonymous complaint policy, which may be contained within any code of business conduct of the Company, regarding: (a) the receipt, retention and treatment of complaints received by the Company regarding accounting, internal accounting controls or auditing matters; and (b) the confidential, anonymous submission by our employees of concerns regarding questionable accounting or auditing matters.

The Audit Committee met 6 times during 2025 and all board members were in attendance.

*Compensation Committee*. The Compensation Committee operates pursuant to a charter approved by our Board of Directors, which the Compensation Committee reviews periodically to determine if revisions are necessary or appropriate. A copy of the charter is posted on our website at *https://hkholdingco.com/corporate-documents/*. In addition, a copy of the charter is available upon written request to our General Counsel and Secretary at our principal executive office (470 Park Ave S., New York, New York 10016). The Compensation Committee has oversight responsibility with respect to the structure, operation and effectiveness of our compensation plans, policies and programs for officers and directors, including:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•To review and approve corporate goals and objectives relevant to compensation for executive officers;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•To evaluate the effectiveness of our compensation practices in achieving our strategic objectives to encourage behaviors consistent with our values, and to align performance objectives consistent with our goals and vision;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•To evaluate the performance of our Chief Executive Officer based upon stated goals and objectives and determine and approve the compensation of our Chief Executive Officer;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•To evaluate and approve the compensation of other executive officers, utilizing input and non-binding recommendations from our Chief Executive Officer;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•To review and oversee the preparation of any disclosure relative to our compensation practices provided in our annual report and proxy statement or other materials distributed to shareholders or filed with the SEC;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•To review and approve, or make recommendations to the Board with respect to, the terms of our incentive compensation plans and equity-based plans (collectively, the "Benefit Plans") and oversee the activities of the individuals responsible for administering the Benefit Plans;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•To review and approve all awards pursuant to the Benefit Plans;

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•To evaluate the Benefit Plans and specifically to consider whether the Benefit Plans appropriately reward and provide incentive to participants commensurate with their cost to the Company;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•To make recommendations to the Board with respect to the amendment, termination or replacement of the Benefit Plans;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•To recommend to the Board the compensation for directors;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•To appoint, compensate and oversee any independent compensation consultant to assist with determining or recommending the amount or form of executive and director compensation and to approve all services provided to the Company by such compensation consultant or any of its affiliates;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•To retain or replace any independent counsel or other experts or advisors that the Compensation Committee believes to be necessary or appropriate; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•To recommend to the Board adjustments to director and officer insurance coverage, as appropriate.

The Compensation Committee met 2 times during 2025 and all board members were in attendance.

*Nominating & Corporate Governance Committee*. The Nominating & Corporate Governance Committee operates pursuant to a charter approved by our Board of Directors, which the Nominating & Corporate Governance Committee reviews periodically to determine if revisions are necessary or appropriate. A copy of the charter is posted on our website at *https://hkholdingco.com/corporate-documents/*. In addition, a copy of the charter is available upon written request to our General Counsel and Secretary at our principal executive office (470 Park Ave S., New York, New York 10016). The Nominating and Corporate Governance Committee's role is to determine the appropriate composition of the Board and on that basis recommend a slate of director nominees for election to the Board, to identify and recommend candidates to fill vacancies between annual meetings of shareholders, and to review, evaluate, and recommend changes to our corporate governance framework. The principal responsibilities and functions of the Nominating & Corporate Governance Committee are to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Seek and identify individuals qualified to become members of the Board, consistent with its nominating criteria;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Consider and nominate nominees for election at each annual meeting of our shareholders;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Review with the Board at least annually the qualifications of new and existing members of the Board, considering the level of independence of individual members, together with such other factors as the Board may deem appropriate, including overall skills, financial literacy and experience, to ensure our ongoing compliance with applicable standards; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•At the direction of the Board, consider various corporate governance policies and procedures.

The Nominating & Corporate Governance Committee met once during 2025 and all board members were in attendance.

*<u>B</u><u>oard Leadership Structure</u>*

Historically, the Company combined the roles of Chairman of the Board and Chief Executive Officer and saw Mr. Stahl serve as Chairman of the Board, Chief Executive Officer and Chief Investment Officer. The Board of Directors had determined that Mr. Stahl's knowledge of the Company and the Company's industry, combined with his extensive experience with the Company, made him the logical and natural choice to serve as Chairman of the Board. Mr. Stahl served as Chairman of the Board, Chief Executive Officer and Chief Investment Officer of the Company during 2025 until his passing on April 7, 2026. Following his passing, the Board appointed Steven Bregman and Peter Doyle as Co-Chief Executive Officers and is currently evaluating the Board's leadership structure, including the appointment of a Chairman.

------

In addition, the Board has designated Daniel J. Roller, one of our non-management directors, to serve as our lead independent director. The lead independent director serves as the liaison between management and the non-management directors. The lead independent director and each of the other directors communicate regularly with the Chairman of the Board regarding appropriate agenda topics and other matters related to the Board.

*<u>Management Succession Planning and Development</u>* 

The planning and execution of leadership succession is one of the most important functions of the Board. It was with great sadness that in April 2026, with the passing of our co-founder Mr. Murray Stahl, we were required to implement a leadership transition. We are pleased to have developed sufficient senior leadership talent within the organization to enable us to fill our executive positions with highly qualified internal candidates.

Our new Chief Executives, working with the Nominating and Governance Committee and the Board, will continue to evaluate the need for any leadership transitions.

*<u>Board's Role in Risk Oversight</u>*

The Board's role in our risk oversight process includes receiving regular reports from members of our management regarding areas of material risk to the Company, including operational, financial, legal and regulatory, cybersecurity, and strategic risks. The Audit Committee is responsible for oversight of risks relating to accounting matters, financial reporting, cybersecurity, and legal and regulatory compliance. To satisfy these oversight responsibilities, the Audit Committee meets regularly with management and our independent registered public accounting firm. The Compensation Committee is responsible for overseeing risks relating to employment policies and our compensation and benefits programs. To satisfy these oversight responsibilities, the Compensation Committee meets regularly with management to understand the implications of compensation decisions, particularly the risks our compensation policies may pose to our financial condition and stockholders. The Nominating & Corporate Governance Committee is responsible for overseeing risks relating to overall corporate governance. To satisfy these oversight responsibilities, the Nominating & Corporate Governance Committee annually reviews Board composition, as well as Board and committee performance, and periodically reports to the Board on corporate governance matters.

*<u>Risks Related to Compensation Policies and Practices</u>*

As part of its oversight of our executive and non-executive compensation programs, the Compensation Committee considers the impact on our risk profile of our compensation programs, including incentive awards. The Compensation Committee reviews factors that may influence excessive risk-taking, to determine whether they present a material risk to the Company. The Compensation Committee also utilizes these risk mitigating factors:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Overall compensation levels that are competitive with market;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Discretionary authority to reduce annual cash incentive awards;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Internal controls over financial reporting and other financial, operational and compliance policies and practices that are intended to prevent manipulation of performance; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Maintain key risk mitigating policies, including a clawback policy to recover incentives for financial restatements due to misconduct or fraud.

*<u>Stockholder Recommendations for Director Candidates</u>*

The Board of Directors has delegated specific responsibilities to the Nominating & Corporate Governance Committee relating to selection of directors to serve on the Board. The Nominating & Corporate Governance Committee is responsible for seeking and identifying individuals qualified to become members of the Board, consistent with its nominating criteria, and considering and nominating nominees for election at each annual meeting of our shareholders. The Nominating & Corporate Governance Committee seeks to identify director candidates who (i) have significant business experience that is relevant and beneficial to the Board and HKHC, (ii) are willing and able to make a sufficient time commitment to the affairs of HKHC to effectively perform the duties of a director, including regular attendance at Board and committee meetings, (iii) are committed to the long-term growth and

------

profitability of HKHC, (iv) are individuals of character and integrity, (v) are individuals with inquiring minds willing to challenge and stimulate management, and (vi) represent the interests of HKHC as a whole and not just the interests of a particular stockholder or group. The Nominating & Corporate Governance Committee believes these criteria are the key factors in identifying qualified director candidates.

The Nominating & Corporate Governance Committee has a policy for considering new director candidates recommended by our stockholders if such recommendations are made in compliance with applicable laws, rules and regulations, our Bylaws, and procedures established by the Nominating & Corporate Governance Committee. Director candidates recommended by stockholders are evaluated by the Nominating & Corporate Governance Committee using the same criteria described in the previous paragraph. Stockholders may submit their recommendations to the attention of the Board of Directors by following the procedures provided below under the heading "Communications with the Board."

Under our Bylaws, stockholders can nominate persons for election to our Board of Directors. Any director nomination must comply with the requirements set forth in our Bylaws and must be received by our Secretary at our principal executive offices between the close of business on February 14, 2027 and the close of business on March 16, 2027.

*<u>Communications with the Board</u>*

Stockholders or other interested parties may communicate with the Board of Directors or particular Board members by mailing a written communication to our General Counsel and Secretary at our principal executive office at 470 Park Ave S., New York, New York 10016, by email to legal@horizonkinetics.com, or by telephone to (646) 291-2300. Our General Counsel and Secretary will forward correspondence to its intended addressee.

The Board encourages stockholder communication with the Board and company management. The Company conducts ongoing stockholder outreach and holds meetings or calls with requesting stockholders.

Stockholders may also communicate with Board members at the Company's annual meeting of stockholders, as it is our policy that Board members should attend such meetings and make themselves available to address any matters properly brought before the meetings. Instructions for methods to communicate with Board members at any annual meeting of stockholders will be explained at the outset of the meeting.

**Director Compensation**

On August 14, 2025, the Board set the compensation for non-management directors at $100,000 per year, inclusive of service on all committees, paid in cash on a quarterly basis.

**2025 Director Summary Compensation Table**

The following table reflects information concerning the compensation of our directors earned during the last completed fiscal year ended December 31, 2025. Directors who are also officers of the Company do not receive any additional compensation for their services on the Board.

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp;Name | Fees Earned or Paid in Cash ($) | &nbsp;&nbsp;Stock Awards | Total ($) |
| &nbsp;&nbsp;Murray Stahl (1) | $- | 0 | $- |
| &nbsp;&nbsp;Steven Bregman(1) | $- | 0 | $- |
| &nbsp;&nbsp;Peter Doyle(1) | $- | 0 | $- |
| &nbsp;&nbsp;Daniel J. Roller | $100000 | 0 | $100000 |
| &nbsp;&nbsp;Alice C. Brennan | $100000 | 0 | $100000 |
| &nbsp;&nbsp;Allison Nagelberg | $100000 | 0 | $100000 |
| &nbsp;&nbsp;Brent D. Rosenthal | $100000 | 0 | $100000 |

---

(1) Messrs. Stahl, Bregman and Doyle did not receive any additional compensation for service on the Board. Mr. Stahl passed away on April 7, 2026.

------

**EXECUTIVE OFFICERS**

Biographical information regarding our executive officers during 2025 is as follows:

*Murray Stahl* served as Chairman of the Board, Chief Executive Officer and Chief Investment Officer of the Company during fiscal year 2025 until his passing on April 7, 2026. Mr. Stahl co-founded Horizon Kinetics and served in senior leadership roles for more than three decades. He previously served in such roles for Horizon Kinetics, LLC, a Delaware limited liability company and wholly-owned subsidiary of HKHC ("Horizon Kinetics"), and is one of its co-founders. He had more than thirty years of investing experience and was responsible for overseeing Horizon Kinetics' proprietary research. Prior to co-founding Horizon Kinetics, Mr. Stahl spent 16 years at Bankers Trust Company (1978-1994) as a senior portfolio manager and research analyst. He received a Bachelor of Arts in 1976 and a Master of Arts in 1980 from Brooklyn College, and an MBA from Pace University in 1985.

*Steven Bregman*, age 67. See biographical information in the "Proposal 1 – Election of Directors" section.

*Peter Doyle*, age 63. See biographical information in the "Proposal 1 – Election of Directors" section.

*Mark Herndon*, age 56, is our Chief Financial Officer. Mr. Herndon joined Horizon Kinetics as Chief Financial Officer in 2024. He is responsible for overseeing all financial reporting functions of the Company. Mr. Herndon also serves as the Chief Financial Officer of Consensus Mining & Seigniorage Corporation (OTCQX: CMSG). Previously, Mr. Herndon was Senior Vice President and Chief Financial Officer at Safeguard Scientifics, Inc. (NASDAQ: SFE) from 2018 to 2023, a company that provided capital and relevant expertise to a portfolio of private entities. Prior to 2018, Mr. Herndon spent 27 years at PricewaterhouseCoopers serving in a variety of client service and national office roles, including as Assurance Partner from 2006 through 2018. Mr. Herndon earned a BBA in Accounting from Georgia Southern University and an MBA from Emory University's Goizueta Business School.

*Alun Williams*, age 54, is our Chief Operating Officer. He joined Horizon Kinetics in 2009 and, after 12 years as the firm's Director of Trading and Operations, took over the role of Chief Operating Officer in 2021. As Chief Operating Officer, Mr. Williams is responsible for overseeing daily operations and administrative functions for the Company. Prior to 2009, Mr. Williams was at Goldman Sachs where he was the head of GSAM Operations Salt Lake City. He joined Goldman Sachs in 1996 and in his time there held a number of operational and control positions within the equity, private wealth and asset management divisions. He is also a member of the Board of Directors and the President of Consensus Mining & Seigniorage Corporation (OTCQX: CMSG) and a member of the Board of Directors of the Horizon Kinetics ICAV, a regulated UCITS fund. Mr. Williams received a BSc in Business Administration from Bath University, England.

*Jay Kesslen*, age 53, is our General Counsel and Secretary. He joined Horizon Kinetics in 1999 and previously served as General Counsel, Managing Director and a member of the Board of Horizon Kinetics. He oversees all aspects of the Company's legal affairs, advises on all material compliance matters, and is responsible for the firm's corporate governance. Mr. Kesslen is Horizon Kinetics' Anti-Money Laundering Officer and also serves as a director for several private funds managed by subsidiaries of Horizon Kinetics. He is also Vice President and Assistant Secretary for Kinetics Mutual Funds, Inc., and Vice President for RENN Fund, Inc., a closed-end fund. Mr. Kesslen also serves as the General Counsel of FRMO Corp. (OTCID: FRMO) and Consensus Mining and Seigniorage Corporation (OTCQX: CMSG). Mr. Kesslen holds a BA in Economics from the State University of New York at Plattsburgh (cum laude) and a JD from Albany Law School.

*Russell Grimaldi*, age 46, is our Chief Compliance Officer and Associate General Counsel. He joined Horizon Kinetics in 2005 and previously served as the Chief Compliance Officer and Associate General Counsel of Horizon Kinetics. He oversees Horizon Kinetics' compliance program and supports all legal and regulatory functions. He also serves as Secretary and Chief Compliance Officer for RENN Fund, Inc., a closed-end fund, and for Consensus Mining and Seigniorage Corporation (OTCQX: CMSG) and as Chief Compliance Officer for Kinetics Mutual Funds, Inc., a series of open-end funds. Mr. Grimaldi holds a BA in Legal Studies from Quinnipiac University (cum laude) and a JD from Albany Law School.

There are no family relationships among the directors and executive officers of HKHC.

------

**EXECUTIVE COMPENSATION**

**Executive Summary**

The Company is a "smaller reporting company" under Item 10 of Regulation S-K, and the following compensation disclosure is intended to comply with the requirements applicable to smaller reporting companies.

**Named Executive Officers**

This section provides information regarding our executive compensation program for the following executive officers of the Company (collectively, the "named executive officers" or "NEO"):

---

| | |
|:---|:---|
| &nbsp;&nbsp;**Name** | &nbsp;&nbsp;**Position** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Murray Stahl | &nbsp;&nbsp;Chief Executive Officer and Chief Investment Officer (served during 2025 until his passing April 2026) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Steven Bregman | &nbsp;&nbsp;Co-Chief Executive Officer (appointed April 2026) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Peter Doyle | &nbsp;&nbsp;Co-Chief Executive Officer (appointed April 2026) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Jay Kesslen | &nbsp;&nbsp;General Counsel and Secretary |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Alun Williams | &nbsp;&nbsp;Chief Operating Officer |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mark Herndon | &nbsp;&nbsp;Chief Financial Officer |

---

**Fiscal Year 2025 Performance Highlights**

The Company delivered strong financial and strategic results during 2025.

Highlights of the Company's 2025 financial results include the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•The Company's total revenues grew 31% in 2025 as a result of higher average assets under management ("AUM") at our mutual funds.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•The Company's operating expenses decreased $9.1 million, or 13%, in 2025 due to primarily to lower commission and bonus payments associated with the 2024 incentive fee.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•The Company ended the year ended December 31, 2025 with $9.6 billion of AUM.

Highlights of the Company's 2025 strategic results include the following

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•The Company launched several new private funds and investment products. While these products individually represent a small portion of AUM, we believe they provide growth opportunities for the future.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•During the third quarter, the Company consummated an agreement to sell its assets related to our consumer products and discontinued those operations.

**Overview of Our Executive Compensation Program**

The intellectual capabilities of our employees are among our most important assets. Our financial results depend on the level of assets we manage, our ability to provide outstanding client service, develop new client relationships, generate competitive long-term investment performance, and build strong relationships with clients, investment consulting firms, and other financial intermediaries.

We believe that the expertise and commitment of our NEO are critical to delivering superior long-term results to our clients and stockholders and to achieving our overall business objectives.

On November 11, 2025, the Compensation Committee approved the Company's executive compensation program (the "Program") for the 2026 calendar year. The material elements of the Program include base salaries and discretionary bonuses. Base salaries are used to provide a fixed amount of compensation for an executive officer's regular work, are reviewed annually and may be adjusted from time to time by the Compensation Committee. Bonuses are discretionary, are paid in the form of cash awards only and are paid out of a general pool for executive officers.

------

For the 2026 calendar year, the bonus pool will be based on a percentage of incentive fees earned by the Company, which may be adjusted from time to time at the discretion of the Compensation Committee. The Company does not currently intend to pay its executive officers in the form of stock awards, options, or any other form of equity-based compensation, but will reassess at appropriate times in the future. The Company does not have employment agreements with any of its executive officers.

On November 11, 2025, the Compensation Committee approved the compensatory arrangements set forth in the following table:

---

| | | | |
|:---|:---|:---|:---|
| **2026** | **2026** | **2026** | **2026** |
| Name and Title | **<u>Salary</u>** | **<u>Bonus</u>** | **<u>Total</u>** |
| &nbsp;&nbsp;Jay Kesslen, General Counsel and Secretary | $1050000 | TBD | $1050000 |
| &nbsp;&nbsp;Alun Williams, Chief Operating Officer | $1050000 | TBD | $1050000 |
| &nbsp;&nbsp;Mark Herndon, Chief Financial Officer | $580000 | TBD | $580000 |

---

**Compensation Philosophy and Objectives**

In designing and implementing our executive compensation program, the Compensation Committee is guided by the following philosophy and objectives:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Supporting the Company's overall business strategy and ensuring it is designed to attract, retain and motivate highly qualified professionals within the Company's industry;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Reviewing compensation practices and trends to assess the adequacy and competitiveness of the Company's executive compensation program as compared to companies in the same or similar industry; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Evaluating the efficacy of the Company's compensation policy and strategy in achieving expected benefits to the Company.

*Market Compensation Data.*

In making its pay decisions, the Compensation Committee considered market compensation data from a group of similarly situated publicly traded asset managers that the Compensation Committee felt constituted a proper peer group.

**2025 Summary Compensation Table**

The following table summarizes all compensation earned by our NEO for the years indicated.

------

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| Name and Principal Position | Year | Salary ($) | Bonus ($) | Stock Awards ($) | Option Awards ($) | Non-Equity Incentive Plan Compensation ($) | Non-qualified Deferred Compensation Earnings ($) | All Other Compensation(1) ($) | Total ($) |
| Murray Stahl | 2025 | $410000 | $- | $- | $- | $- | $- | $- | $410000 |
| Chief Executive Officer and Chief Investment Officer (Served in 2025 until his passing April 7, 2026) | 2024 | $386400 | $- | $- | $- | $- | $- | $19590 | $405990 |
| Jay Kesslen | 2025 | $1000000 | $23262 | $- | $- | $- | $- | $- | $1023262 |
| General Counsel and Secretary | 2024 | $775000 | $375000 | $- | $- | $- | $- | $- | $1150000 |
| Alun Williams | 2025 | $1000000 | $23262 | $- | $- | $- | $- | $- | $1023262 |
| Chief Operating Officer | 2024 | $550000 | $600000 | $- | $- | $- | $- | $- | $1150000 |
| Mark Herndon | 2025 | $525000 | $15508 | $- | $- | $- | $- | $- | $540508 |
| Chief Financial Officer | 2024 | $350000 | $260000 | $- | $- | $- | $- | $- | $610000 |

---

(1) The Company paid expenses associated with the healthcare benefits for Mr. Stahl.

***Narrative Disclosure to Summary Compensation Table***

For 2025 and 2024, the principal components of compensation for our NEO were base salary and bonuses.

*Base Salaries*

Base salaries are used to provide a fixed amount of compensation for an executive officer's regular work, are reviewed annually and may be adjusted from time to time by the Compensation Committee.

*Bonuses*

Bonuses are discretionary, are paid in the form of cash awards only and are paid out of a general pool for executive officers. For the 2026 fiscal year, the bonus pool will be based on a percentage of incentive fees earned by the Company, which may be adjusted from time to time at the discretion of the Compensation Committee.

*No Equity-Based Compensation or Employment Agreements*

The Company does not currently intend to pay its executive officers in the form of stock awards, options, or any other form of equity-based compensation, but will reassess at appropriate times in the future. The Company has no employment agreements with any of its executive officers.

<u>Other Benefits and Perquisites</u>

*Employee Benefits*

We offer employee and post-retirement benefits to all full-time employees, including NEO, in order to provide them with financial support in the event of injury, illness, or disability and to help them accumulate retirement savings on a tax-favored basis. Our employees are generally eligible to participate in benefit programs including medical, dental, vision, disability, life insurance, and health savings or flexible spending accounts. The cost of health insurance and savings plans is partially borne by the Company, including costs for NEO. We pay for disability insurance and a set amount of term life insurance for all employees.

*Perquisites*

We did not provide perquisites to our NEO during 2025 or 2024.

------

**Outstanding Equity Awards at December 31, 2025**

Our NEO did not have any outstanding equity awards as of December 31, 2025.

We do not currently grant stock options or stock appreciation rights ("SARs") as part of our equity compensation programs. During 2025, (a) the Compensation Committee and the Board did not award any options or SARs to a NEO, and (b) the Company did not time the disclosure of material nonpublic information to affect the value of executive compensation. However, if stock options or SARs were to be granted in the future, the Company would not grant such awards in anticipation of the release of material nonpublic information that is likely to result in changes to the price of our common stock.

**Insider Trading Policy**

The Company has adopted an insider trading policy governing the purchase, sale, and/or other disposition of Company securities by directors, officers, and employees and by the Company. We believe that the policies and procedures set forth in our insider trading policy are reasonably designed to promote compliance with insider trading laws, rules and regulations.

Pay-Versus-Performance Disclosure

In accordance with rules adopted by the SEC pursuant to the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, we provide the following disclosure regarding the relationship between executive compensation and our financial performance for the fiscal years listed below. The Compensation Committee did not consider the pay versus performance disclosure below in making its pay decisions for any of the years shown. For fiscal year 2025, the Company's Principal Executive Officer ("PEO") was Murray Stahl, who served as Chief Executive Officer during the year until his passing on April 7, 2026.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Summary Compensation Total for PEO** | **Compensation Actually Paid to PEO** | **Average Summary Compensation Total for Non-PEO NEO's** | **Average Compensation Actually Paid to Non-PEO NEO's** | **Value of Initial Fixed $100 Investment Based on Total Shareholder Return (1)** | **Net Income (000's) (2)** |
| &nbsp;&nbsp;2025 | $410000 | $410000 | $862344 | $862344 | $112 | $5118 |
| &nbsp;&nbsp;2024 | $405990 | $386400 | $970000 | $970000 | $170 | $92472 |

---

(1) On August 1, 2024, the Company, formerly known as "Scott's Liquid Gold-Inc.," completed its previously announced merger in accordance with the terms and conditions of the Agreement and Plan of Merger, dated December 19, 2023, as amended (collectively, the "Merger Agreement"), by and among Scott's, Horizon Kinetics and HKNY One, LLC, a Delaware limited liability company and wholly-owned subsidiary of Scott's ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into Horizon Kinetics, with Horizon Kinetics surviving the merger as a wholly-owned subsidiary of the Company (the "Merger"). As a result of the Merger, the Company became a publicly traded company on the OTC markets (HKHC). Values in this column assume $100 was invested in the Company for the period starting upon the completion of the Merger , with dividends reinvested, through the end of the listed year.

(2) Net Income for the fiscal year 2025 includes a period prior to the Merger.

***Description of Relationship Between PEO and Non-PEO NEO Compensation Actually Paid and Company Total Stockholder Return ("TSR")***

The chart above sets forth the relationship between Compensation Actually Paid to our PEO, the average of Compensation Actually Paid to our Non-PEO NEO, and the Company's cumulative TSR for the fiscal years listed.

------

***Description of Relationship Between PEO and Non-PEO NEO Compensation Actually Paid and Net Income***

The chart above sets forth the relationship between Compensation Actually Paid to our PEO, the average of Compensation Actually Paid to our Non-PEO NEO, and our Net Income during the fiscal years listed.

**PROPOSAL 2: RATIFICATION OF APPOINTMENT OF CBIZ CPAs P.C. AS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**

Our Audit Committee has appointed CBIZ CPAs P.C., formerly Marcum LLP, as our independent registered public accounting firm for the year ending December 31, 2026. Representatives of CBIZ will attend the annual meeting to answer questions and may make a statement, if they so desire.

**Previous Independent Registered Public Accounting Firm**

On August 13, 2024, the Audit Committee dismissed Weinberg & Company ("Weinberg") as the Company's independent registered public accounting firm. Weinberg had served in that capacity since December 2023.

On August 13, 2024, the Audit Committee appointed Marcum LLP as the Company's independent registered public accounting firm, and on November 1, 2024, CBIZ CPAs P.C. acquired the attest business from Marcum LLP. Accordingly, on April 28, 2025, the Company replaced Marcum LLP with CBIZ CPAs P.C. as the Company's independent registered public accounting firm.

Weinberg's report on Scott's consolidated financial statements for the year ended December 31, 2023 did not contain an adverse opinion or a disclaimer of opinion, nor was it qualified or modified as to uncertainty, audit scope or accounting principles.

During the year ended December 31, 2023, and during the subsequent interim period through August 13, 2024, (i) there were no disagreements (within the meaning of Item 304(a)(1)(iv) of Regulation S-K and the related instructions thereto) between the Company and Weinberg on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedures, which disagreements, if not resolved to Weinberg's satisfaction, would have caused such Weinberg to make reference to the subject matter of the disagreements in connection with its report on the Company's consolidated financial statements for the relevant year, and (ii) there were no reportable events (as defined by Item 304(a)(1)(v) of Regulation S-K), except for the material weaknesses in internal control over financial reporting (A) first identified as of June 30, 2023 related to Scott's finance department lacking a sufficient number of trained professionals with technical accounting expertise to process and account for complex, non-routine transactions in accordance with GAAP, which continued to exist at June 30, 2024; and (B) first identified on June 30, 2022 related to the operating effectiveness of the review of the impairment assessment of goodwill prepared by a third-party firm.

During the year ended December 31, 2023, and during the subsequent interim period through August 13, 2024, neither the Company nor anyone on its behalf consulted with CBIZ CPAs P.C. regarding (i) the application of accounting principles to a specified transaction, either completed or proposed, or the type of audit opinion that might be rendered on the Company's consolidated financial statements, and neither a written report nor oral advice was provided to the Company that CBIZ CPAs P.C. concluded was an important factor considered by the Company in reaching a decision as to any accounting, auditing or financial reporting issue, (ii) any matter that was either the subject of a disagreement (as defined in Item 304(a)(1)(iv) of Regulation S-K and the related instruction thereto), or (iii) any reportable event (as described in Item 304(a)(1)(v) of Regulation S-K).

In accordance with Item 304(a)(3) of Regulation S-K, the Company provided Weinberg with a copy of the disclosure set forth above and requested that Weinberg furnish the Company with a letter addressed to the SEC stating whether Weinberg agrees with the statements made by the Company with respect to Weinberg in the disclosure, and, if not, stating the respects in which it does not agree. A copy of Weinberg's letter is filed as Exhibit 16.1 to the Company's Current Report on Form 8-K filed with the SEC on August 19, 2024.

------

**Audit and Non-Audit Fees**

Aggregate fees that we were billed for the fiscal years ended December 31, 2025 and 2024 by our independent registered public accounting firm, CBIZ CPAs P.C., were as follows:

---

| | | |
|:---|:---|:---|
|  | Fiscal Year ended December 31, | Fiscal Year ended December 31, |
|  | **<u>2025</u>** | **<u>2024</u>** |
| &nbsp;&nbsp;Audit fees(1) | $590000 | $520150 |
| &nbsp;&nbsp;Audit-related fees(2) | 489700 | 413920 |
| &nbsp;&nbsp;Tax fees(3) | 231337 | 5897 |
| &nbsp;&nbsp;All other fees | - | - |
| &nbsp;&nbsp;Total | $1311037 | $939967 |

---

(1) Includes the aggregate fees billed for professional services in connection with the audit of our 2025 and 2024 annual financial statements, the review of the financial statements included in our Form 10-Qs, as well as for services that are normally provided in connection with statutory or regulatory filings or engagements.

(2) Includes the aggregate fees billed for professional services in connection with the audit of the Company's proprietary funds.

(3) Includes the aggregate fees for pre-approved services associated with tax compliance and tax consulting.

*Pre-approval policies and procedures for audit and non-audit services*. The Audit Committee has established a policy regarding pre-approval of all audit and non-audit services provided by our independent registered public accounting firm. Each year, the Audit Committee considers for approval the independent registered public accounting firm's engagement to render audit services, as well as a list prepared by management of anticipated non-audit services and related budget estimates. During the course of the year, our management and the independent registered public accounting firm are responsible for tracking all services and fees to ensure that they are within the scope pre-approved by the Audit Committee. To ensure prompt handling of unexpected matters, the Audit Committee has delegated to its chairperson the authority to represent the Audit Committee in reviewing and approving audit and non-audit services; however, the Audit Committee must ratify any such actions by the chairperson.

The Audit Committee or the chairperson acting on its behalf pre-approved all non-audit services provided by CBIZ CPAs P.C. for the year ended December 31, 2025 and 2024.

**Vote Sought and Recommendation**

Although stockholder action on this matter is not required, the appointment of CBIZ CPAs P.C. is being recommended to the stockholders for ratification. The ratification of the appointment of CBIZ CPAs P.C. as HKHC's independent registered public accounting firm for the year ending December 31, 2026 requires the affirmative "FOR" vote of a majority of the shares present in person or represented by proxy at the annual meeting (meaning that of the shares represented at the annual meeting and entitled to vote, a majority of them must be voted "FOR" the proposal for it to be approved). You may vote "FOR," "AGAINST," or "ABSTAIN" with respect to this proposal. This proposal is considered a "routine" matter for which banks, brokers, and other nominees may vote in their discretion on behalf of beneficial owners who have not provided voting instructions. Abstentions will have the same effect as a vote "AGAINST" this proposal.

**THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS A VOTE <u>FOR</u> THE RATIFICATION OF THE APPOINTMENT OF CBIZ CPAs P.C. AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR 2026.**

**PROPOSAL 3: approvAL, on a non-binding, advisory basis, OF the compensation of HKHC's named executive officers**

Pursuant to Section 14A of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), we are providing stockholders with an opportunity to vote, on a non-binding advisory basis, on the compensation of our

------

named executive officers as disclosed in this proxy statement in accordance with SEC rules. The advisory vote on executive compensation described in this proposal is commonly referred to as a "say-on-pay vote."

As described under "Executive Compensation — Overview of Our Executive Compensation Program" elsewhere in this proxy statement, the material elements of our executive compensation program include base salaries and discretionary bonuses. Base salaries are used to provide a fixed amount of compensation for an executive officer's regular work, are reviewed annually and may be adjusted from time to time by the Compensation Committee. Bonuses are discretionary, are paid in the form of cash awards only and are paid out of a general pool for executive officers. The Company does not currently intend to pay its executive officers in the form of stock awards, options, or any other form of equity-based compensation, but will reassess at appropriate times in the future. The Company has no employment agreements with any of its executive officers.

This proposal gives our stockholders the opportunity to express their views on the overall compensation of our named executive officers provided by us and the philosophy, policies and practices described in this proxy statement. For the reasons discussed above, we are asking our stockholders to indicate their support for the compensation of our named executive officers by voting "FOR" the following resolution at the Annual Meeting:

"RESOLVED, that the Company's stockholders approve, on an advisory basis, the compensation of the named executive officers, as disclosed pursuant to the compensation disclosure rules of the SEC (which disclosure includes the executive compensation section, the compensation tables, and the narrative discussion)."

The say-on-pay vote is advisory only, and therefore it will not bind the Company or the Board. However, the Board and the Compensation Committee will consider the voting results as appropriate when making future decisions regarding executive compensation.

**Vote Sought and Recommendation**

The proposal to approve, on a non-binding, advisory basis, the compensation of HKHC's named executive officers requires the affirmative "FOR" vote of a majority of the shares present in person or represented by proxy at the annual meeting. You may vote "FOR," "AGAINST," or "ABSTAIN" with respect to this proposal. Abstentions will have the same effect as a vote "AGAINST" this proposal, and broker non-votes will have no effect on the vote for this proposal.

**THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS A VOTE <u>FOR</u> APPROVAL, ON A NON-BINDING, ADVISORY BASIS, OF THE COMPENSATION PAID TO THE NEO, AS DISCLOSED IN THIS PROXY STATEMENT PURSUANT TO THE COMPENSATION DISCLOSURE RULES OF THE SEC.**

------

**CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS**

Certain co-founders of Horizon Kinetics, LLC, a Delaware limited liability company and wholly-owned subsidiary of HKHC, are also shareholders of FRMO Corporation ("FRMO"). FRMO has a right to a 4.2% share of the Company's gross revenue (prior to any commission sharing agreements) and a 4.4% ownership interest in the Company. The Company's expenses under this agreement are included with sales, distribution and marketing expenses in the Company's condensed consolidated statement of operations.

The Company has waived, or provides discounted management and advisory fees, for assets under management in proprietary funds or separately managed accounts for shareholders' and their direct families, FRMO, Horizon Common Inc., Kinetics Holding Corporation and employees of the Company.

The Company has a services agreement with Consensus Mining & Seigniorage Corporation ("CMSG", OTCQX: CMSG) under which it performs various cryptocurrency mining operations on behalf of CMSG, and in addition, certain officers and employees of the Company also serve in a similar role for CMSG. The Company has a similar services agreement with Winland Holdings Corporation (OTC: WELX) and certain officers and employees of the Company also serve a similar role for WELX.

As of December 31, 2025, the Company owned 196,122 shares of FRMO common stock as well as 36,969 shares of CMSG.

**Review and Approval of Related Party Transactions**

All future material transactions involving affiliated parties will be subject to approval by a majority of our unaffiliated directors. We have a written policy, entitled the "Conflict of Interest Policy," that addresses the review and approval of related-party transactions. The Policy provides that, except with the Board's prior knowledge and consent, no director, officer, or employee of HKHC or its subsidiaries may be involved in a transaction or relationship that gives rise to a "conflict of interest" with HKHC. The policy defines "conflict of interest" as an occurrence where a director, officer, or employee's private interests interfere, or appear to interfere, in any way with our interests taken as a whole and specifically includes all related-party transactions and relationships that we are required to disclose in our proxy statement.

In the event that the Board's consent to a conflict of interest is sought, the request must be addressed to our compliance officer (or, where the matter involves the compliance officer, to the Audit Committee) and referred to the Audit Committee for its consideration. If the matter involves any member of the Audit Committee, the matter is required to be addressed by the unaffiliated members of the Board of Directors. A majority of the members of the Audit Committee (or a majority of the unaffiliated members of the Board of Directors, where applicable) must approve any request. The terms of any such transaction must be as favorable to us as the terms would be if the transaction were entered into with an unrelated third party.

------

**SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT**

As of April 24, 2026, there were 18,635,321 shares of our common stock issued and outstanding. Except where otherwise indicated, the following table sets forth certain information as of April 24, 2026 regarding beneficial ownership of our common stock held by:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•each person known to us to be the beneficial owner of more than 5% of our outstanding common stock;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•each director and director nominee;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•each named executive officer; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•all of our directors and executive officers as a group.

Such information (other than with respect to our directors and executive officers) is based on a review of statements filed with the SEC pursuant to Sections 13(d), 13(f) and 13(g) of the Exchange Act with respect to our common stock. Except as noted below, the shares beneficially owned are shares of our common stock and the address for all beneficial owners in the table below is 470 Park Ave S., New York, New York 10016.

---

| | | |
|:---|:---|:---|
| **<u>Name of Beneficial Owner</u>** | **<u>Number of Shares Beneficially Owned</u><u>(1)</u>** | **<u>Percentage of Shares Beneficially Owned</u><u>(1)</u>** |
| &nbsp;&nbsp;Greater than 5% Owner |  |  |
| &nbsp;&nbsp;Horizon Common, Inc. (2) | 8216801 | &nbsp;&nbsp;44.1% |
| &nbsp;&nbsp;Named Executive Officers, Directors and Director Nominees: |  |  |
| &nbsp;&nbsp;Murray Stahl (3) | 9303588 | &nbsp;&nbsp;49.9% |
| &nbsp;&nbsp;Steven Bregman (4) | 9305235 | &nbsp;&nbsp;49.9% |
| &nbsp;&nbsp;Peter Doyle (5) | 9937720 | &nbsp;&nbsp;53.3% |
| &nbsp;&nbsp;Mark Herndon | 200 | &nbsp;&nbsp;\*% |
| &nbsp;&nbsp;Alun Williams | 50 | &nbsp;&nbsp;\*% |
| &nbsp;&nbsp;Jay Kesslen | 350 | &nbsp;&nbsp;\*% |
| &nbsp;&nbsp;Russell Grimaldi | 132 | &nbsp;&nbsp;\*% |
| &nbsp;&nbsp;Daniel J. Roller (6) | 245566 | &nbsp;&nbsp;1.3% |
| &nbsp;&nbsp;Alice C. Brennan | 1000 | &nbsp;&nbsp;\*% |
| &nbsp;&nbsp;Allison Nagelberg | 400 | &nbsp;&nbsp;\*% |
| &nbsp;&nbsp;Brent D. Rosenthal | 1750 | &nbsp;&nbsp;\*% |
| &nbsp;&nbsp;All executive officers, directors and director nominees as a group (12 persons) | 10200935 | &nbsp;&nbsp;54.7% |

---

\* Less than 1%

(1) The number of shares are those beneficially owned, as determined under the rules of the SEC, and such information is not necessarily indicative of beneficial ownership for any other purpose. Under such rules, beneficial ownership includes any shares as to which a person has sole or shared voting power or investment power and any shares which the person has the right to acquire within 60 days through the exercise of any option, warrant or right, through conversion of any security or pursuant to the automatic termination of a power of attorney or revocation of a trust, discretionary account or similar arrangement. Percentages are calculated in accordance with applicable SEC rules and are based on the number of shares issued and outstanding on April 6, 2026.

(2) Horizon Common, Inc. acquired shares pursuant to the Merger on August 1, 2024.

(3) Represents shares beneficially owned by the estate and family of Mr. Stahl following his passing on April 7, 2026.

------

(4) Mr. Bregman received 248,197 shares directly in connection with the Merger on August 1, 2024. In addition, Mr. Bregman is deemed to beneficially own the 8,216,801 shares reported by Horizon Common, Inc., and 823,923 shares owned by FRMO Corp., which were also primarily received in connection with the Merger. Mr. Bregman disclaims beneficial ownership over the shares held by Horizon Common, Inc., FRMO Corp. and other entities, except to the extent of his pecuniary interest therein.

(5) Mr. Doyle received 880,457 shares directly in connection with the Merger on August 1, 2024. In addition, Mr. Doyle is deemed to beneficially own the 8,216,801 shares reported by Horizon Common, Inc., and 823,923 shares owned by FRMO Corp., which were also received in connection with the Merger. Mr. Doyle disclaims beneficial ownership over the shares held by Horizon Common, Inc., FRMO Corp. and other entities, except to the extent of his pecuniary interest therein.

(6) Mr. Roller directly owns 9,500 shares and as the sole managing member of Maran Partners, LP, Maran Partners GP, LLC, Maran SPV GP, LLC, Maran SPV, LP, Maran Partners Fund LP, and Maran Partners Fund, LP, is deemed to beneficially own the shares of common stock owned by the foregoing entities.

------

**REPORT OF THE AUDIT COMMITTEE**

The Audit Committee operates pursuant to a charter approved by our Board of Directors, which the Audit Committee reviews periodically to determine if revisions are necessary or appropriate. A copy of the charter is posted on our website at https://hkholdingco.com/corporate-documents/. In addition, a copy of the charter is available upon written request to our General Counsel and Secretary at our principal executive office (470 Park Ave S., New York, New York 10016). The Audit Committee monitors (1) the integrity of our financial statements, (2) our independent auditor's qualifications and independence, (3) the performance of our independent auditors, and (4) our compliance with legal and regulatory requirements. The Audit Committee has the sole authority to appoint or replace our independent auditor, and pre-approves all audit engagement fees and terms and all non-audit services with the independent auditors

In discharging its oversight responsibilities, the Audit Committee reviewed and discussed the audited consolidated financial statements of Horizon Kinetics Holding Corporation ("HKHC") as of and for the fiscal year ended December 31, 2025 with management and CBIZ CPAs P.C., our independent registered public accounting firm. Management is responsible for HKHC's financial reporting process, including its system of internal control over financial reporting (as defined in Rule 13a-15(f) and 15d-15(f) promulgated under the Securities Exchange Act of 1934), and for the preparation of HKHC's consolidated financial statements, in accordance with generally accepted accounting principles ("GAAP"). CBIZ CPAs P.C. is responsible for auditing those financial statements and expressing an opinion on the conformity of the financial statements with GAAP. The Audit Committee's responsibility is to monitor and review these processes.

The Audit Committee reviews HKHC's financial reporting process on behalf of the Board of Directors. In performance of its oversight function, the Audit Committee has met and held discussions with management and CBIZ CPAs P.C. with respect to our audited consolidated financial statements for fiscal year 2025 and related matters. Management advised the Audit Committee that HKHC's consolidated financial statements were prepared in accordance with GAAP, and the Audit Committee has reviewed and discussed the consolidated financial statements with management and CBIZ CPAs P.C. CBIZ CPAs P.C. presented to and reviewed with the Audit Committee the matters required to be discussed by the applicable standards adopted by the Public Company Accounting Oversight Board. CBIZ CPAs P.C. also provided to the Audit Committee the written disclosures and the letter from CBIZ CPAs P.C. required by applicable requirements of the Public Company Accounting Oversight Board regarding CBIZ CPAs P.C.'s communications with the Audit Committee concerning independence, and, in connection therewith, the Audit Committee discussed with CBIZ CPAs P.C. their views as to their independence. The Audit Committee also reviewed, among other things, the audit and non-audit services performed by, and the amount of fees paid for such services to, CBIZ CPAs P.C. The Audit Committee meetings regularly include executive sessions with CBIZ CPAs P.C. without the presence of our management.

In undertaking its oversight function, the Audit Committee relied, without independent verification, on management's representation that the financial statements have been prepared with integrity and objectivity and in conformity with GAAP and on the representations of CBIZ CPAs P.C. included in their report on HKHC's financial statements. The Audit Committee is not, however, professionally engaged in the practice of accounting or auditing and does not provide any expert or other special assurance or professional opinion as to the sufficiency of the external or internal audits or whether HKHC's financial statements are complete and accurate and are in accordance with GAAP.

Based on the Audit Committee's considerations, discussions with management and discussion with CBIZ CPAs P.C. as described above, the Audit Committee recommended to the Board of Directors that the audited consolidated financial statements be included in our Annual Report on Form 10-K for the year ended December 31, 2025 filed with the SEC.

AUDIT COMMITTEE

Brent D. Rosenthal (Chair)

Daniel J. Roller

Alice C. Brennan

Allison Nagelberg

------

**SECTION 16(A) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE**

Section 16(a) of the Exchange Act requires our directors, executive officers, and persons who own more than 10 percent of our common stock to file with the SEC initial statements of beneficial ownership of securities and subsequent changes in beneficial ownership. Our officers, directors, and greater-than-10-percent stockholders are required by the SEC's regulations to furnish us with copies of all Section 16(a) forms they file.

To our knowledge, based solely on a review of the copies of such reports furnished to us and written representations that no other reports were required, we believe that our officers, directors, and greater-than-10-percent beneficial owners complied in a timely fashion with all Section 16(a) filing requirements applicable to them during the fiscal year ended December 31, 2025, with the exception of the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Form 3 filed on May 5, 2025, pertaining to the beneficial ownership of 8,216,437 shares of our common stock by Horizon Common Inc.; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Form 4 filed on May 5, 2025, pertaining to 15 open market purchases of our common stock and one open market sale of our common stock by Horizon Common Inc.

**STOCKHOLDER PROPOSALS AND DIRECTOR NOMINATIONS**

Stockholders may present proper proposals for inclusion in our proxy statement and form of proxy for consideration at the 2027 annual meeting of stockholders, pursuant to Rule 14a-8 under the Exchange Act, by submitting their proposals to our Secretary in a timely manner. Such proposals must be received at our principal executive offices no later than the close of business on December 25, 2026. Proposals should be submitted in writing to 470 Park Ave S., New York, New York 10016, Attn: Secretary. Such stockholder proposals must comply with all applicable legal requirements, including Rule 14a-8 under the Exchange Act and our Bylaws.

Additionally, our Bylaws provide for advance notice procedures to nominate a person for director or to propose business to be considered by stockholders at a meeting (other than pursuant to Rule 14a-8). To be considered timely under these provisions, the stockholder's notice must provide the information set forth in our Bylaws and be received by our Secretary at our principal executive offices at the address set forth on the first page of this proxy statement between not later than the close of business February 14, 2027 and the close of business on March 16, 2027; provided, however, that if the date of the 2026 Annual Meeting of stockholders is more than 30 days before or more than 60 days after the one-year anniversary of the 2026 Annual Meeting of Stockholders, notice of such stockholder proposal must be received no earlier than the close of business on the 120th day before the 2027 Annual Meeting of stockholders and no later than the close of business on the later of the two following dates: the 90th day prior to 2027 Annual Meeting of stockholders, or the 10th day following the day on which public announcement of the date our 2027 Annual Meeting of stockholders is first made. Our Bylaws also specify requirements as to the form and content of a stockholder's notice.

Additionally, to comply with the SEC's universal proxy rules, stockholders who intend to solicit proxies in support of director nominees other than the Company's nominees must provide notice by April 10, 2027 and do so by following the procedures prescribed in SEC Rule 14a-19.

**ANNUAL REPORT**

Our 2025 Annual Report to Stockholders, which includes our consolidated financial statements as of and for the year ended December 31, 2025, is being mailed to you along with this proxy statement. Upon written request, we will provide, without charge to stockholders, a copy of our 2025 Form 10-K, including the financial statements and financial statement schedules to such report. Requests should be directed to Horizon Kinetics Holding Corporation, 470 Park Ave S., New York, New York 10016, Attn: Secretary.

**HOUSEHOLDING OF PROXY MATERIALS**

Unless we have received contrary instructions, we may send a single copy of this proxy statement and notice of annual meeting to any household at which two or more stockholders reside if we believe the stockholders are members of the same family. Each stockholder in the household will continue to receive a separate proxy card. This process,

------

known as "householding," reduces the volume of duplicate information received at any one household and helps to reduce our expenses. However, if stockholders prefer to receive multiple sets of our disclosure documents at the same address this year or in future years, they should follow the instructions described below. Similarly, if an address is shared with another stockholder and both stockholders would like to receive only a single set of our disclosure documents, they should follow these instructions:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•If the shares are registered in the name of the stockholder, stockholders should contact us at our offices at Horizon Kinetics Holding Corporation, 470 Park Ave S., New York, New York 10016, Attn: Secretary, or by telephone at (646) 291-2300, to inform us of the request.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•If a bank, broker, or other nominee holds the shares, stockholders should contact the bank, broker, or other nominee directly.

**OTHER MATTERS**

Our Board of Directors knows of no other matters that will be presented for consideration at the Annual Meeting. If any other matters are properly brought before the meeting, it is the intention of the persons named as proxy holder in the accompanying proxy to vote on such matters in their discretion.

By Order of the Board of Directors,

/s/Steven Bregman

/s/Peter Doyle

Steven Bregman and Peter Doyle

Co-Chief Executive Officers

April 20, 2026

------

![img223293286_2.jpg](img223293286_2.jpg)

HORIZON KINIETICS Holding Corporation BROADRIDGE CORPORATE ISSUER SOLUTIONS C/O HORIZON KINETICS HOLDING CORPORATION 470 PARK AVENUE S, 4TH FL S NEW YORK, NY 10016 SCAN TO VIEW MATERIALS & VOTE VOTE BY INTERNET Before The Meeting - Go to www.proxyvote.com or scan the QR Barcode above Use the Internet to transmit your voting instructions and for electronic delivery of information up until 11:59 p.m. Eastern Time on June 8, 2026. Have your proxy card in hand when you access the web site and follow the instructions to obtain your records and to create an electronic voting instruction form. During The Meeting - Go to www.virtualshareholdermeeting.com/HKHC2026 You may attend the meeting via the Internet and vote during the meeting. Have the information that is printed in the box marked by the arrow available and follow the instructions. ELECTRONIC DELIVERY OF FUTURE PROXY MATERIALS If you would like to reduce the costs incurred by our company in mailing proxy materials, you can consent to receiving all future proxy statements, proxy cards and annual reports electronically via e-mail or the Internet. To sign up for electronic delivery, please follow the instructions above to vote using the Internet and, when prompted, indicate that you agree to receive or access proxy materials electronically in future years. VOTE BY PHONE - 1-800-690-6903 Use any touch-tone telephone to transmit your voting instructions up until 11:59 p.m. Eastern Time on June 8, 2026. Have your proxy card in hand when you call and then follow the instructions. VOTE BY MAIL Mark, sign and date your proxy card and return it in the postage-paid envelope we have provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717. TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS: V95069-P50682 KEEP THIS PORTION FOR YOUR RECORDS THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED. DETACH AND RETURN THIS PORTION ONLY Horizon Kinetics Holding Corporation ("HKHC") The Board of Directors recommends that you vote FOR the following proposals: 1. Election of Directors Nominees: For Withhold 1a. Steven Bregman 1b. Peter Doyle 1c. Daniel J. Roller 1d. Alice C. Brennan 1e. Allison Nagelberg 1f. Brent D. Rosenthal 2. The ratification of the appointment of CBIZ CPAs P.C. as HKHC's independent registered public accounting firm for the year ending December 31, 2026. 3. To approve, on a non-binding, advisory basis, the compensation of HKHC's named executive officers. NOTE: In their discretion, the proxies are authorized to vote upon such other matters that may properly come before the meeting and any adjournments or postponements thereof. The shares represented by this proxy, when properly executed, will be voted in the manner directed herein by the undersigned stockholder(s). If no direction is made, this proxy will be voted FOR the election of the director nominees named herein, and FOR proposals 2 and 3. For Against Abstain Please indicate if you plan to attend this meeting. Yes No Please sign exactly as your name(s) appear(s) hereon. When signing as attorney, executor, administrator, or other fiduciary, please give full title as such. Joint owners should each sign personally. All holders must sign. If a corporation or partnership, please sign in full corporate or partnership name by authorized officer. Signature [PLEASE SIGN WITHIN BOX] Date Signature (Joint Owners) Date

------

![img223293286_3.jpg](img223293286_3.jpg)

Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting:The Notice and Proxy Statement, Annual Report and Form 10-K are available at www.proxyvote.com. V95070-P50682 HORIZON KINETICS HOLDING CORPORATION ("HKHC") THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORSANNUAL MEETING OF SHAREHOLDERS JUNE 9, 2026 The shareholder(s) hereby appoint(s) Peter Doyle and Jay Kesslen, or either of them, as proxies, each with the power to appoint his substitute, and hereby authorize(s) them to represent and to vote, as designated on the reverse side of this ballot, all of the shares of (Common) Stock of HKHC that the shareholder(s) is/are entitled to vote at the Annual Meeting of Shareholders to be held at 2:00 p.m., Eastern Time on Tuesday, June 9, 2026, located at the offices of Horizon Kinetics Holding Corporation,470 Park Avenue South, 3rd Floor, New York, New York 10016, and virtually at www.virtualshareholdermeeting.com/HKHC2026, and any adjournment or postponement thereof. THIS PROXY, WHEN PROPERLY EXECUTED, WILL BE VOTED AS DIRECTED BY THE SHAREHOLDER(S). IF NO SUCH DIRECTIONS ARE MADE, THIS PROXY WILL BE VOTED FOR THE ELECTION OF THE NOMINEES LISTED ON THE REVERSE SIDE FOR THE BOARD OF DIRECTORS, AND FOR PROPOSALS 2 AND 3. PLEASE MARK, SIGN, DATE AND RETURN THIS PROXY CARD PROMPTLY USING THE ENCLOSED REPLY ENVELOPE CONTINUED AND TO BE SIGNED ON REVERSE SIDE

------